49
Participants
Start Date
February 1, 2024
Primary Completion Date
September 30, 2026
Study Completion Date
September 30, 2027
Single drug chemotherapy plus immunotherapy
The choice of chemotherapy plus immunotherapy for squamous cell carcinoma is gemcitabine or paclitaxel or vinorelbine. Paclitaxel or pemetrexed are available for monotherapy for non-squamous and non-small cell lung cancer. Immunotherapy drugs can be Pembrolizumab /Penpulimab/ Camrelizumab/ Tislelizumab / Sintilimab/ sulgarizumab and so on
RECRUITING
Hubei Cancer Hospital, Wuhan
Hubei Cancer Hospital
OTHER